If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Related content
Volume 3, Number 2, April 2005

< previous issue | all issues | next issue >

Review article

Favourites:Add to Favourites

Targeting Small Arteries of Hypertensive Status with Novel ATP-Sensitive Potassium Channel Openers#
pp. 119-124(6)
Authors: Wang, Hai; Zhang, Ying-Li; Chen, Yu-Ping

Favourites:Add to Favourites

Somatostatin: A Hormone for the Heart?
pp. 125-131(7)
Authors: Badway, Amy C.; Blake, Allan D.

Favourites:Add to Favourites

Is the Vascular System a Main Target for Thyroid Hormones? From Molecular and Biochemical Findings to Clinical Perspectives
pp. 133-145(13)
Authors: Sabatino, Laura; Colantuoni, Antonio; Iervasi, Giorgio

Favourites:Add to Favourites

Are the Antioxidant Properties of Carvedilol Important for the Protection of Cardiac Mitochondria?
pp. 147-158(12)
Authors: Oliveira, Paulo J.; Goncalves, Lino; Monteiro, Pedro; Providencia, Luis A.; Moreno, Antonio J.

Favourites:Add to Favourites

Urotensin II: A Vascular Mediator in Health and Disease
pp. 159-168(10)
Authors: Kemp, William; Roberts, Stuart; Krum, Henry

Favourites:Add to Favourites
Favourites:Add to Favourites
Favourites:Add to Favourites

Obesity and Cardiovascular Physiology: Impact of some Pharmacological Agents
pp. 185-193(9)
Authors: Chaput, Jean-Philippe; Berube-Parent, Sonia; Tremblay, Angelo

Favourites:Add to Favourites

Dihydropyridines, Nitric Oxide and Vascular Protection
pp. 195-205(11)
Author: Crespi, Francesco

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more